Dyslipidemia, characterized by changes in low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and apolipoprotein A-I (ApoA-I) levels, presents a complex association with AF risk [16]. This evidence concerns the gene APOA1 and metabolic syndrome.